CAR T Voices – CAR T

About the CAR T Closer to Home Campaign

There is an urgent need to expand CAR T-cell therapy access across Canada. This specialized treatment is a newer option for patients with certain blood cancers, yet significant barriers within our healthcare system are limiting its full implementation and impact.

Canada's healthcare system stakeholders need to continue to work together to address the pressing need to further enhance capacity for CAR T therapy in Canada through targeted healthcare system investments.

À propos de la campagne Thérapie CAR-T plus proche

Il faut de toute urgence améliorer l’accès au traitement par cellules CAR-T partout au Canada. Ce traitement spécialisé est une option récente pour les patients atteints de certains cancers du sang. Toutefois, d’importants obstacles au sein même du système de santé limitent la mise en œuvre complète du traitement et son impact.

Les intervenants du système de santé canadien doivent continuer de travailler ensemble pour répondre ce besoin pressant et continuer d’améliorer la capacité de traitement par cellules CAR-T au Canada grâce à des investissements ciblés dans le système de santé.

Hear from Canadians across the country about their experience with CAR T

Between 2019 and 2024, 669 patients have been treated with CAR T therapies in Canada.³ Here are just a few of their stories and experiences from across the country from patients who have had the treatment or may need CAR T in the future.

Casper, Montreal, QC

Roger, Sainte-Croix, QC

Linda, St. Johns, NLD

Serge & Marie, Sainte-Flavie QC

Charlotte, Toronto, ON

Patrick, Terrebonne, QC

David Perry, British Columbia

If you have any questions about this campaign or would like to connect with the Gilead team about how we can work together to make CAR T available to more people, please contact us at: publicaffairscanada@gilead.ca